The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.
This year's sympoisum had an overall topic of Drug Induced Disease from a Patient Safety perspective. This presentation deals with secondary cancers resulting from primary cancer treatment.
|The activity met the following learning objectives for Pharmacists:|
|· Describe the role of dietary modification for LDL modification
|· Identify how some dietary supplement ingredients mimic the mechanisms of action of prescription drugs|
|· Describe the magnitude of plant sterols and stanols, red yeast rice, silybum M, berberine, cinnamon, green tea extract, and garlic LDL reduction as monotherapy|
|· Describe the potential for combination therapy to increase the magnitude of benefit|
|· Compare and contrast with prescription LDL lowering options|
|· Describe risks of contamination and adulteration with dietary supplements|
Activity Release Dates
Released: April 27, 2023
Expires: April 27, 2026
ACPE UAN Codes
1.0 hours of CE
|The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.|
Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive 1.0 CE Hour for completing the activity (ACPE UAN 0009-0000-23-010-H01-P), passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.
C. Michael White, PharmD, FCCP, FCP
Professor and Department Head Pharmacy Practice
University of Connecticut School of Pharmacy and Director HOPES Research Group
Dr. White is a co-investigator on a project assessing the risk of bias for an anti-bleeding drug, andexanet alfa. This is a bleeding reversal agent and AstraZeneca is funding it. They do not have a lipid reducing product that I am discussing in this presentation or as a competitor to the products I am discussing. nonetheless.
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.